The Effect Of Ultrasound-guided Modified Pectoral Nerves Block Versus Ketamine Plus Magnesium Infusion On Analgesic Profile In Breast Cancer Surgeries
1 other identifier
interventional
75
1 country
1
Brief Summary
Background: Postoperative pain is one of the greatest patient concerns following surgery. However, general anesthesia cannot provide adequate postoperative pain control and the routine use of parenteral opioids aggravates postoperative sedation, nausea, emesis, impaired oxygenation and depressed ventilation. Hypothesis: The investigators assume that both ultrasound guided Modified Pecs Block and combination of Ketamine and Magnesium sulphate infusion can achieve better analgesia in major breast cancer surgery in the form of reducing total amount of intraoperative fentanyl requirement and reducing postoperative morphine requirement and improvement of postoperative VAS scores both at rest and during shoulder movement so we plan this study to evaluate this assumption
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 postoperative-pain
Started Nov 2017
Longer than P75 for phase_3 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 12, 2017
CompletedFirst Submitted
Initial submission to the registry
June 28, 2019
CompletedFirst Posted
Study publicly available on registry
September 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedOctober 27, 2020
October 1, 2020
3.3 years
June 28, 2019
October 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
total morphine requirements
calculating the total dose of morphine consumed in postoperative analgesia
24 hours postoperatively
Secondary Outcomes (4)
fentanyl consumption
intraoperative period
Visual analogue scale score
immediately after recovery and then at 1, 4, 8, 12, and 24 hours postoperatively.
Sedation score
A sedation level recorded upon arrival to the PACU and at 1, 4, 8, 12, and 24 hours postoperatively.
Nausea and vomiting
during the first post-operative 24 hours
Study Arms (3)
pectoral nerves block group
ACTIVE COMPARATORmodified pectoral nerves block was performed on the side of surgery
Ktamine plus Magnesium group
ACTIVE COMPARATORPatients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the induction of general anesthesia. This was followed by intraoperative continuous infusion of 10 mg/kg/h of magnesium sulphate combined with infusion of 0.1mg/kg/h ketamine that was started before skin incision and continued until completion of skin closure via infusion pump
Control Group
ACTIVE COMPARATORNormal saline infusion with similar rate and volume to KM infusion was used as a placebo
Interventions
ultrasound guided block of nerve supply of surgical site
Patients received 40 mg/kg of magnesium sulphate infusion in 100cc normal saline, as a bolus dose, in addition to 0.2mg/kg of ketamine as a bolus dose, 15 min before the induction of general anesthesia. This was followed by intraoperative continuous infusion of 10 mg/kg/h of magnesium sulphate combined with infusion of 0.1mg/kg/h ketamine that was started before skin incision and continued until completion of skin closure via infusion pump (Atom Syringe Pump S-1235).
Normal saline infusion with similar rate and volume to KM infusion was used as a placebo.
Eligibility Criteria
You may qualify if:
- female patients with American society of Anesthesia classification(ASA) II physical status undergoing major breast cancer surgery with axillary evacuation under general anesthesia.
- Patients' age from18 to 65 Years.
- Body mass index (BMI) are from 20 to 40 kg/m2.
You may not qualify if:
- Pregnant patients
- Patients having sensitivity or contraindication to test drugs or regional anesthesia.
- severe respiratory or cardiac disorders.
- history of psychological disorder.
- chronic pain .
- significant liver or renal insufficiency. .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Cancer Institute
Al Haram, Giza Governorate, 12555, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Anesthesia and pain medicine
Study Record Dates
First Submitted
June 28, 2019
First Posted
September 19, 2019
Study Start
November 12, 2017
Primary Completion
March 11, 2021
Study Completion
April 15, 2021
Last Updated
October 27, 2020
Record last verified: 2020-10